QIAGEN launches the new LIAISON LymeDetect Assay based on QuantiFERON in partnership with DiaSorin selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
Message :
Required fields DIASORIN, IN PARTNERSHIP WITH QIAGEN, LAUNCHES THE NEW LIAISON® LYMEDETECT® ASSAY BASED ON QUANTIFERON TECHNOLOGY IN COUNTRIES ACCEPTING CE MARK FOR EARLY DIAGNOSIS OF LYME BORRELIOSIS THE LIAISON® LYMEDETECT® ASSAY IS A SOLUTION FOR THE EARLY DIAGNOSIS OF LYME BORRELIOSIS COMBINING DETECTION OF IGG AND IGM ANTIBODIES AND CELLULAR IMMUNITY THE TEST IS AVAILABLE IN COUNTRIES ACCEPTING THE CE MARK AND IS DESIGNED TO BE RUN ON
THE LIAISON® XL AND LIAISON® XS PLATFORMS IN CLINICAL STUDIES, THE ASSAY SHOWED, WITHIN 21 DAYS FROM THE FIRST EVIDENCE OF INFECTION, A SENSITIVITY OF 74% VERSUS THAT OF EXISTING ESTABLISHED METHODS AT 49%, WHILE ALSO DEMONSTRATING A HIGH DIAGNOSTIC SPECIFICITY OF 100%
AMC Health, Superior Leader in Remote Patient Monitoring (RPM) and Telehealth Adds Dean Panovich as Chief Revenue Officer
News provided by
Share this article
Share this article
NEW YORK, April 19, 2021 /PRNewswire/ AMC Health, the leader in telehealth and remote patient monitoring (RPM), providing access to care for Payers, Providers, and the largest telehealth provider in the world, the Veterans Affairs, announced today that Dean Panovich has joined as Chief Revenue Officer (CRO).
Dean Panovich
With nearly two-decades of remote care expertise, AMC Health has continued to experience significant growth, serving tens-of-thousands of enrolled patients. As CRO, Dean will oversee all growth areas that include Sales, Account Management, Product Management and Marketing. His addition to AMC Health will support their market growth and profitability.
DiaSorin to acquire Luminex Corporation for USD 37 00 per share or approximately USD 1 8 billion apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Healthcare industry leader brings deep expertise in AI, clinical workflows, and consumer-driven technology to drive value-based care cost, quality and outcomes for health systems
ST. LOUIS (BUSINESS WIRE) Lumeris today announced the appointment of Jean-Claude Saghbini as Chief Technology Officer and member of its Executive Committee. Jean-Claude brings to Lumeris more than 20 years of technology and healthcare experience, ranging from startups to Fortune 20 companies. He will lead the development of Lumeris’ next-generation integrated population health and managed care solutions and technologies to improve healthcare outcomes and reduce variability in care.
“Jean-Claude has both the passion and expertise to create scalable solutions that seamlessly integrate clinical workflows and advanced technologies like voice and AI to support point of care decisions, increase care quality, lower costs and improve patient safety,” said Mike Long, CEO and Chairman of Lumeris. “He wil